Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hitoshi Kiyoi

Showing results (1-10 of 270) with videos related to

Pageof 27
Sort By:
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|July 13, 2010
[FLT3 kinase inhibitors for the treatment of acute leukemia]Hitoshi Kiyoi
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|September 22, 2006
[Mutation of the nucleophosmin gene in acute myeloid leukemia]Hitoshi Kiyoi
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|May 24, 2006
[The present status of, and problems with the development of FLT3 kinase inhibitors]Hitoshi Kiyoi
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|October 6, 2011
[Progress of pathophysiology and therapeutic evidence in AML]Hitoshi Kiyoi
Nagoya Journal of Medical Science|March 24, 2015
FLT3 INHIBITORS: RECENT ADVANCES AND PROBLEMS FOR CLINICAL APPLICATIONHitoshi Kiyoi
Nihon Rinsho. Japanese Journal of Clinical Medicine|May 4, 2007
[Novel molecularly target therapies for leukemia]Hitoshi Kiyoi
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|November 18, 2015
[The Cutting-edge of Medicine; Genetic alterations and their prognostic implications in acute myeloid leukemia]Hitoshi Kiyoi
Nihon Rinsho. Japanese Journal of Clinical Medicine|July 15, 2014
[FLT3 inhibitors for acute myeloid leukemia]Hitoshi Kiyoi
Rinsho Byori. the Japanese Journal of Clinical Pathology|November 4, 2015
[Necessity of Genetic Examination in Treatment for Hematological Malignancies]Hitoshi Kiyoi
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|May 10, 2019
[Acute myeloid leukemia: AML]Hitoshi Kiyoi
Pageof 27

Showing results (1-10 of 270) with videos related to

Sort By:
Pageof 27
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|July 13, 2010
[FLT3 kinase inhibitors for the treatment of acute leukemia]Hitoshi Kiyoi
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|September 22, 2006
[Mutation of the nucleophosmin gene in acute myeloid leukemia]Hitoshi Kiyoi
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|May 24, 2006
[The present status of, and problems with the development of FLT3 kinase inhibitors]Hitoshi Kiyoi
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|October 6, 2011
[Progress of pathophysiology and therapeutic evidence in AML]Hitoshi Kiyoi
Nagoya Journal of Medical Science|March 24, 2015
FLT3 INHIBITORS: RECENT ADVANCES AND PROBLEMS FOR CLINICAL APPLICATIONHitoshi Kiyoi
Nihon Rinsho. Japanese Journal of Clinical Medicine|May 4, 2007
[Novel molecularly target therapies for leukemia]Hitoshi Kiyoi
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|November 18, 2015
[The Cutting-edge of Medicine; Genetic alterations and their prognostic implications in acute myeloid leukemia]Hitoshi Kiyoi
Nihon Rinsho. Japanese Journal of Clinical Medicine|July 15, 2014
[FLT3 inhibitors for acute myeloid leukemia]Hitoshi Kiyoi
Rinsho Byori. the Japanese Journal of Clinical Pathology|November 4, 2015
[Necessity of Genetic Examination in Treatment for Hematological Malignancies]Hitoshi Kiyoi
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|May 10, 2019
[Acute myeloid leukemia: AML]Hitoshi Kiyoi
Pageof 27